Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

Pfizer CEO Albert Bourla plans to meet key executives of activist hedge fund Starboard Value next week, the Financial Times ...

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...

Activist investor Starboard Value has built a $1bn position in Pfizer, according to two people familiar with the matter, as ...

Starboard Value has taken a stake in Pfizer, people familiar with the matter said.The drug giant's stock price has dropped ...

Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

Starboard has prepared a pitch deck about its turnaround plans for Pfizer but this has yet to be circulated to the drugmaker’s directors and investors, said two people familiar with the matter. But ...

Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of ...

Pfizer (NYSE: PFE) was a stock on the move Wednesday, and not because of any news generated by the healthcare company.